ETF Holdings Breakdown of TWST

Stock NameTwist Bioscience Corp
TickerTWST(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS90184D1000
LEI549300T23BL59LCOH584

News associated with TWST

Twist Bioscience Corporation (NASDAQ:TWST) Stock Position Lifted by Farther Finance Advisors LLC
Farther Finance Advisors LLC lifted its holdings in Twist Bioscience Corporation (NASDAQ:TWST – Free Report) by 18.5% in the 1st quarter, HoldingsChannel reports. The firm owned 6,435 shares of the company’s stock after purchasing an additional 1,006 shares during the quarter. Farther Finance Advisors LLC’s holdings in Twist Bioscience were worth $251,000 as of its […] - 2025-06-19 08:11:03
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by GAMMA Investing LLC
GAMMA Investing LLC increased its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 6,499.1% in the first quarter, Holdings Channel reports. The firm owned 29,366 shares of the company’s stock after buying an additional 28,921 shares during the period. GAMMA Investing LLC’s holdings in Twist Bioscience were worth $1,153,000 at the […] - 2025-06-16 07:12:56
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stake in Twist Bioscience Co. (NASDAQ:TWST)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lowered its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 3.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 67,129 shares of the company’s stock after selling 2,641 shares during the period. MIRAE ASSET […] - 2025-05-21 08:40:50
Twist Bioscience Co. (NASDAQ:TWST) Stock Position Raised by BNP Paribas Financial Markets
BNP Paribas Financial Markets lifted its holdings in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 138.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 90,527 shares of the company’s stock after purchasing an additional 52,495 shares during the quarter. BNP Paribas Financial Markets’ holdings in Twist Bioscience were worth […] - 2025-05-15 08:04:51
Twist Bioscience Co. (NASDAQ:TWST) Shares Acquired by Price T Rowe Associates Inc. MD
Price T Rowe Associates Inc. MD grew its stake in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 15.5% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 41,401 shares of the company’s stock after acquiring an additional 5,554 shares during the period. Price T Rowe Associates […] - 2025-05-08 07:58:48
Mariner LLC Raises Stake in Twist Bioscience Co. (NASDAQ:TWST)
Mariner LLC raised its stake in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 32.1% in the fourth quarter, Holdings Channel reports. The institutional investor owned 11,559 shares of the company’s stock after buying an additional 2,812 shares during the quarter. Mariner LLC’s holdings in Twist Bioscience were worth $537,000 at the end […] - 2025-05-02 08:08:53
Envestnet Asset Management Inc. Purchases 19,340 Shares of Twist Bioscience Co. (NASDAQ:TWST)
Envestnet Asset Management Inc. increased its position in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 53.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 55,194 shares of the company’s stock after purchasing an additional 19,340 shares during the […] - 2025-04-27 08:22:48
Russell Investments Group Ltd. Grows Position in Twist Bioscience Co. (NASDAQ:TWST)
Russell Investments Group Ltd. grew its stake in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 186.3% during the 4th quarter, Holdings Channel reports. The fund owned 8,911 shares of the company’s stock after acquiring an additional 5,798 shares during the period. Russell Investments Group Ltd.’s holdings in Twist Bioscience were worth $414,000 at the […] - 2025-04-24 07:44:48
Brokerages Set Twist Bioscience Co. (NASDAQ:TWST) Target Price at $52.80
Shares of Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) have been given an average recommendation of “Moderate Buy” by the ten ratings firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell rating, one has given a hold rating and eight have issued a buy […] - 2025-04-21 05:30:48
Twist Bioscience Co. (NASDAQ:TWST) Shares Purchased by Pictet Asset Management Holding SA
Pictet Asset Management Holding SA grew its position in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 27.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 8,131 shares of the company’s stock after purchasing an additional 1,764 shares during […] - 2025-04-10 08:38:59
Twist Bioscience Co. (NASDAQ:TWST) Shares Sold by Wellington Management Group LLP
Wellington Management Group LLP decreased its position in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 1.4% during the 4th quarter, HoldingsChannel reports. The fund owned 786,312 shares of the company’s stock after selling 11,425 shares during the quarter. Wellington Management Group LLP’s holdings in Twist Bioscience were worth $36,540,000 at the end […] - 2025-04-07 08:27:05
JPMorgan Chase & Co. Has $83.61 Million Holdings in Twist Bioscience Co. (NASDAQ:TWST)
JPMorgan Chase & Co. decreased its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 27.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,799,212 shares of the company’s stock after selling 676,061 shares during the period. JPMorgan Chase & Co.’s holdings […] - 2025-04-04 08:19:16
Prudential Financial Inc. Trims Stock Position in Twist Bioscience Co. (NASDAQ:TWST)
Prudential Financial Inc. lessened its stake in shares of Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 18.1% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 99,139 shares of the company’s stock after selling 21,967 shares during the period. Prudential Financial Inc.’s holdings in Twist Bioscience […] - 2025-04-01 09:04:53
Victory Capital Management Inc. Raises Position in Twist Bioscience Co. (NASDAQ:TWST)
Victory Capital Management Inc. boosted its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 12.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 372,291 shares of the company’s stock after purchasing an additional 40,482 shares during the period. Victory Capital […] - 2025-03-12 07:55:01
Keybank National Association OH Acquires 4,691 Shares of Twist Bioscience Co. (NASDAQ:TWST)
Keybank National Association OH grew its holdings in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 83.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,334 shares of the company’s stock after acquiring an additional 4,691 shares during the period. Keybank National […] - 2025-03-10 07:54:53
Twist Bioscience Co. (NASDAQ:TWST) Receives Consensus Recommendation of “Moderate Buy” from Analysts
Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the ten ratings firms that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eight have given a buy rating to the […] - 2025-03-04 06:46:55
State of New Jersey Common Pension Fund D Boosts Holdings in Twist Bioscience Co. (NASDAQ:TWST)
State of New Jersey Common Pension Fund D grew its stake in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 12.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,803 shares of the company’s stock after buying an additional […] - 2025-02-21 09:37:03
Twist Bioscience Co. (NASDAQ:TWST) Shares Bought by KBC Group NV
KBC Group NV grew its stake in Twist Bioscience Co. (NASDAQ:TWST – Free Report) by 71.4% during the 4th quarter, Holdings Channel reports. The firm owned 2,942 shares of the company’s stock after purchasing an additional 1,226 shares during the quarter. KBC Group NV’s holdings in Twist Bioscience were worth $137,000 at the end of […] - 2025-02-07 09:50:14
Twist Bioscience Co. (NASDAQ:TWST) Receives $51.90 Consensus Price Target from Analysts
Shares of Twist Bioscience Co. (NASDAQ:TWST – Get Free Report) have been given a consensus rating of “Moderate Buy” by the ten analysts that are covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has given a hold recommendation and eight have assigned a buy recommendation […] - 2025-02-05 06:06:46

TWST institutional holdings

The following institutional investment holdings of TWST have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-26 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 40,796USD 1,507,004 -0.1%
2025-06-26 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 17,024USD 628,867
2025-06-26 IE00BYZK4776 (iShares Healthcare Innovation UCITS ETF USD (Acc)) 67,950USD 2,510,073
2025-06-26 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 29,901USD 1,104,543
2025-06-26 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 29,901USD 1,104,543
2025-06-26 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 434USD 16,032
Total =186,006 USD 6,871,062
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.